Allmed Medical Products Co.,Ltd (SHE:002950)
China
· Delayed Price · Currency is CNY 8.38
-0.10 (-1.18%)
Jun 19, 2025, 10:45 AM CST
SHE:002950 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Operating Revenue | 3,305 | 3,293 | 2,707 | 4,195 | 2,888 | 3,796 | Upgrade
|
| Other Revenue | 33.12 | 33.12 | 49.4 | 15.78 | 37.44 | 38.58 | Upgrade
|
| Revenue | 3,339 | 3,326 | 2,757 | 4,211 | 2,926 | 3,834 | Upgrade
|
| Revenue Growth (YoY) | 24.18% | 20.66% | -34.53% | 43.92% | -23.70% | 63.00% | Upgrade
|
| Cost of Revenue | 2,394 | 2,398 | 2,099 | 2,812 | 2,053 | 2,224 | Upgrade
|
| Gross Profit | 944.71 | 928.04 | 657.93 | 1,399 | 872.17 | 1,610 | Upgrade
|
| Selling, General & Admin | 389.72 | 374.65 | 386.38 | 446.53 | 367.52 | 286.51 | Upgrade
|
| Research & Development | 117.73 | 106.37 | 77.37 | 107.74 | 94.58 | 118.13 | Upgrade
|
| Other Operating Expenses | 23.69 | 10.49 | 13.82 | 26.47 | 19.13 | 4.81 | Upgrade
|
| Operating Expenses | 533.18 | 494.41 | 477.26 | 582.45 | 484.52 | 410.9 | Upgrade
|
| Operating Income | 411.53 | 433.64 | 180.67 | 816.21 | 387.65 | 1,200 | Upgrade
|
| Interest Expense | -22.28 | -25.53 | -31.87 | -35.47 | -17.18 | -17.66 | Upgrade
|
| Interest & Investment Income | 3.34 | 7.16 | 1.87 | 3.09 | 39.97 | 50.58 | Upgrade
|
| Currency Exchange Gain (Loss) | 17.15 | 17.15 | -8.57 | -140.63 | 33.41 | 23.62 | Upgrade
|
| Other Non Operating Income (Expenses) | 1.85 | -1.27 | -3.25 | -6.3 | -6.34 | -0.92 | Upgrade
|
| EBT Excluding Unusual Items | 411.58 | 431.15 | 138.85 | 636.9 | 437.51 | 1,255 | Upgrade
|
| Gain (Loss) on Sale of Investments | -14.68 | -23.28 | -6.88 | -160.19 | 6.13 | 0.48 | Upgrade
|
| Gain (Loss) on Sale of Assets | 28.84 | 28.79 | -0.07 | 3.5 | 1.94 | 26.34 | Upgrade
|
| Asset Writedown | -11.36 | -9.14 | 0.5 | -16.8 | -0.12 | -0.08 | Upgrade
|
| Other Unusual Items | 36.97 | 26.87 | 36.65 | 21.49 | 59.79 | 56.54 | Upgrade
|
| Pretax Income | 451.35 | 454.39 | 169.04 | 484.9 | 505.49 | 1,339 | Upgrade
|
| Income Tax Expense | 90.03 | 85.59 | 64.83 | 80.26 | 73.53 | 178.2 | Upgrade
|
| Earnings From Continuing Operations | 361.32 | 368.8 | 104.22 | 404.64 | 431.96 | 1,160 | Upgrade
|
| Minority Interest in Earnings | -0.02 | -0.12 | 6.18 | 2.15 | -0.75 | -2.94 | Upgrade
|
| Net Income | 361.3 | 368.68 | 110.4 | 406.79 | 431.21 | 1,158 | Upgrade
|
| Net Income to Common | 361.3 | 368.68 | 110.4 | 406.79 | 431.21 | 1,158 | Upgrade
|
| Net Income Growth | 372.94% | 233.95% | -72.86% | -5.66% | -62.75% | 255.27% | Upgrade
|
| Shares Outstanding (Basic) | 625 | 625 | 633 | 633 | 632 | 633 | Upgrade
|
| Shares Outstanding (Diluted) | 625 | 625 | 633 | 633 | 632 | 633 | Upgrade
|
| Shares Change (YoY) | -1.34% | -1.33% | 0.02% | 0.17% | -0.05% | 2.81% | Upgrade
|
| EPS (Basic) | 0.58 | 0.59 | 0.17 | 0.64 | 0.68 | 1.83 | Upgrade
|
| EPS (Diluted) | 0.58 | 0.59 | 0.17 | 0.64 | 0.68 | 1.83 | Upgrade
|
| EPS Growth | 379.36% | 238.44% | -72.87% | -5.82% | -62.73% | 245.58% | Upgrade
|
| Free Cash Flow | 563.57 | 554.64 | 137.02 | 751.68 | 84.16 | 1,193 | Upgrade
|
| Free Cash Flow Per Share | 0.90 | 0.89 | 0.22 | 1.19 | 0.13 | 1.89 | Upgrade
|
| Dividend Per Share | 0.060 | 0.060 | 0.027 | 0.060 | 0.210 | 0.880 | Upgrade
|
| Dividend Growth | 122.22% | 122.22% | -55.00% | -71.43% | -76.14% | 120.00% | Upgrade
|
| Gross Margin | 28.30% | 27.90% | 23.87% | 33.22% | 29.81% | 42.00% | Upgrade
|
| Operating Margin | 12.33% | 13.04% | 6.55% | 19.38% | 13.25% | 31.28% | Upgrade
|
| Profit Margin | 10.82% | 11.08% | 4.00% | 9.66% | 14.74% | 30.19% | Upgrade
|
| Free Cash Flow Margin | 16.88% | 16.68% | 4.97% | 17.85% | 2.88% | 31.12% | Upgrade
|
| EBITDA | 640.37 | 661.52 | 404.67 | 1,008 | 532.77 | 1,342 | Upgrade
|
| EBITDA Margin | 19.18% | 19.89% | 14.68% | 23.95% | 18.21% | 34.99% | Upgrade
|
| D&A For EBITDA | 228.85 | 227.88 | 224 | 192.2 | 145.12 | 142.22 | Upgrade
|
| EBIT | 411.53 | 433.64 | 180.67 | 816.21 | 387.65 | 1,200 | Upgrade
|
| EBIT Margin | 12.33% | 13.04% | 6.55% | 19.38% | 13.25% | 31.28% | Upgrade
|
| Effective Tax Rate | 19.95% | 18.84% | 38.35% | 16.55% | 14.55% | 13.31% | Upgrade
|
| Revenue as Reported | 3,339 | 3,326 | 2,757 | 4,211 | 2,926 | 3,834 | Upgrade
|
| Advertising Expenses | - | 17.97 | 15.98 | - | 27.1 | 8.91 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.